Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SEA-CD40 by Pfizer for Metastatic Melanoma: Likelihood of Approval
SEA-CD40 is under clinical development by Pfizer and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...
Data Insights
SEA-CD40 by Pfizer for Non-Small Cell Lung Cancer: Likelihood of Approval
SEA-CD40 is under clinical development by Pfizer and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...